CenterBook Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
CenterBook Partners's RGEN Position: Q2 2026 in Review
CenterBook Partners sold out of Repligen (RGEN) in Q2 2026, closing a stake of 6,380 shares — an estimated $752K sold.
CenterBook Partners first reported a position in RGEN in Q2 2023 and held it in 3 quarters. The position peaked at $2.36M in Q3 2025. 477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- CenterBook Partners reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
- CenterBook Partners sold 6,380 Repligen shares in Q2 2026, an estimated $752K.
- CenterBook Partners first reported a position in Repligen in Q2 2023 and held it in 3 quarters.
- CenterBook Partners's Repligen position peaked at $2.36M in Q3 2025.
- 477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.